you are responding to a system that makes this intentionally unclear
39 Furthermore, clinical T2D guidelines emphasize individualized therapy, in which the choice of glucose-lowering therapy should include considerations about glucose-reducing effects, desired weight loss, side effects, costs, and patient preferences
Wegovy and Saxenda, both injectables, are the only GLP-1s FDA-approved for obesity
Product Info Molecular formula: N/A (experimental peptide) Molecular weight: N/A Purity: 99%+ Sequence: N/A Most standard lyophilized research vials are commonly prepared using 2mL of bacteriostatic water unless otherwise specified directly on the product page or vial label
Members using the GLP-1 program will track three daily nutrition targets and complete the rings protein, fruits and vegetables and water intakethrough the WeightWatchers app